Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1993 1
1995 1
1996 1
1998 1
1999 5
2000 4
2002 3
2003 2
2004 3
2005 3
2006 6
2007 5
2008 8
2009 12
2010 5
2011 4
2012 6
2013 4
2014 8
2015 4
2016 13
2017 7
2018 6
2019 8
2020 4
2021 11
2022 14
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

130 results
Results by year
Filters applied: . Clear all
Page 1
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update.
Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, Kvien TK, Dougados M, Radner H, Atzeni F, Primdahl J, Södergren A, Wallberg Jonsson S, van Rompay J, Zabalan C, Pedersen TR, Jacobsson L, de Vlam K, Gonzalez-Gay MA, Semb AG, Kitas GD, Smulders YM, Szekanecz Z, Sattar N, Symmons DP, Nurmohamed MT. Agca R, et al. Among authors: de vlam k. Ann Rheum Dis. 2017 Jan;76(1):17-28. doi: 10.1136/annrheumdis-2016-209775. Epub 2016 Oct 3. Ann Rheum Dis. 2017. PMID: 27697765 Review.
Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy: The FINCH 2 Randomized Clinical Trial.
Genovese MC, Kalunian K, Gottenberg JE, Mozaffarian N, Bartok B, Matzkies F, Gao J, Guo Y, Tasset C, Sundy JS, de Vlam K, Walker D, Takeuchi T. Genovese MC, et al. Among authors: de vlam k. JAMA. 2019 Jul 23;322(4):315-325. doi: 10.1001/jama.2019.9055. JAMA. 2019. PMID: 31334793 Free PMC article. Clinical Trial.
Bio-optimized Curcuma longa extract is efficient on knee osteoarthritis pain: a double-blind multicenter randomized placebo controlled three-arm study.
Henrotin Y, Malaise M, Wittoek R, de Vlam K, Brasseur JP, Luyten FP, Jiangang Q, Van den Berghe M, Uhoda R, Bentin J, De Vroey T, Erpicum L, Donneau AF, Dierckxsens Y. Henrotin Y, et al. Among authors: de vlam k. Arthritis Res Ther. 2019 Jul 27;21(1):179. doi: 10.1186/s13075-019-1960-5. Arthritis Res Ther. 2019. PMID: 31351488 Free PMC article. Clinical Trial.
Effect of upadacitinib on reducing pain in patients with active psoriatic arthritis or ankylosing spondylitis: post hoc analysis of three randomised clinical trials.
McInnes IB, Ostor AJK, Mease PJ, Tillett W, Baraliakos X, de Vlam K, Bessette L, Lippe R, Maniccia A, Feng D, Gao T, Zueger P, Saffore C, Kato K, Song IH, Deodhar A. McInnes IB, et al. Among authors: de vlam k. RMD Open. 2022 Mar;8(1):e002049. doi: 10.1136/rmdopen-2021-002049. RMD Open. 2022. PMID: 35332058 Free PMC article. Clinical Trial.
Bone Disease in Axial Spondyloarthritis.
Van Mechelen M, Gulino GR, de Vlam K, Lories R. Van Mechelen M, et al. Among authors: de vlam k. Calcif Tissue Int. 2018 May;102(5):547-558. doi: 10.1007/s00223-017-0356-2. Epub 2017 Oct 31. Calcif Tissue Int. 2018. PMID: 29090349 Review.
Biomarkers in psoriasis and psoriatic arthritis: GRAPPA 2008.
Ritchlin CT, Qureshi AA, de Vlam K, Pitzalis C, Helliwell PS, Mease PJ, Gladman DD, Krueger GG, Kavanaugh AF, Fitzgerald O. Ritchlin CT, et al. Among authors: de vlam k. J Rheumatol. 2010 Feb;37(2):462-7. doi: 10.3899/jrheum.090957. J Rheumatol. 2010. PMID: 20147482
Tofacitinib or adalimumab versus placebo: patient-reported outcomes from OPAL Broaden-a phase III study of active psoriatic arthritis in patients with an inadequate response to conventional synthetic disease-modifying antirheumatic drugs.
Strand V, de Vlam K, Covarrubias-Cobos JA, Mease PJ, Gladman DD, Graham D, Wang C, Cappelleri JC, Hendrikx T, Hsu MA. Strand V, et al. Among authors: de vlam k. RMD Open. 2019 Jan 11;5(1):e000806. doi: 10.1136/rmdopen-2018-000806. eCollection 2019. RMD Open. 2019. PMID: 30713721 Free PMC article. Clinical Trial.
GRAPPA 2019 Research Recipient Awards Report.
Kavanaugh A, Ishchenko A, Lories RJ, de Vlam K, Shi Z, Raychaudhuri SP, Hwang ST. Kavanaugh A, et al. Among authors: de vlam k. J Rheumatol Suppl. 2021 Jun;97:67-68. doi: 10.3899/jrheum.201682. J Rheumatol Suppl. 2021. PMID: 34074673
GRAPPA 2019 Research Recipient Awards Report.
Kavanaugh A, Ishchenko A, Lories RJ, de Vlam K, Shi Z, Raychaudhuri SP, Hwang ST. Kavanaugh A, et al. Among authors: de vlam k. J Rheumatol. 2021 Feb 15:jrheum.201682. doi: 10.3899/jrheum.201682. Online ahead of print. J Rheumatol. 2021. PMID: 33589550
Challenges and Advances in Targeting Remission in Axial Spondyloarthritis.
Baraliakos X, Berenbaum F, Favalli EG, Olivieri I, Ostendorf B, Poddubnyy D, DE Vlam K. Baraliakos X, et al. Among authors: de vlam k. J Rheumatol. 2018 Feb;45(2):153-157. doi: 10.3899/jrheum.170222. J Rheumatol. 2018. PMID: 29419447 Free article. No abstract available.
130 results